Does cardiopulmonary bypass change serum neuron-specific enolase levels?

OBJECTIVE The effects of cardiopulmonary bypass (CPB) on serum neuron-specific enolase (NSE) levels in patients without cognitive dysfunction and neurological deficit are not yet clarified. This study was designed to see the sole effect of extracorporeal circulation on serum NSE levels in patients without any clinically observed neurological deficit. METHODS Thirty-two consecutive patients undergoing first elective open-heart surgery were included in this prospective study. Neurological status was assessed by clinical examination before surgery, and on the postoperative first and second days. Blood samples were obtained after anesthesia induction before the administration of heparin, within the first hour post CPB, 24 and 48 hours after the end of operation. Each blood sample was assayed for hemoglobin (Hb), hematocrit and NSE levels. The Friedman's Test to compare the serial measurements of NSE and hemoglobin samples and the post-hoc Tukey test for paired comparisons between pre and postoperative values were applied Pearson correlation test was used to examine the correlation between NSE concentration and aortic cross-clamping time and CPB time, age, postoperative hematocrit and hemoglobin levels and the amount of blood products transfusion. RESULTS There were no significant differences between NSE values at any sampling time: 11.6+/-8.0 mg/dL, 8.7+/-4.7 mg/dL, 9.3+/-5.4 mg/dL and 8.9+/-5.8 mg/dL, measured preoperatively, at the end of operation, on the first and second post-operative days, respectively. There was no significant correlation between NSE values with any of the compared variables including CPB time. CONCLUSION This study demonstrated that the possible damage of CPB on central nervous system and on blood cells did not reach to the extent of causing any significant increase in serum NSE levels in non-complicated patients undergoing open-heart surgery.

[1]  E. Marcantonio,et al.  Serologic Markers of Brain Injury and Cognitive Function After Cardiopulmonary Bypass , 2006, Annals of surgery.

[2]  F. Maquart,et al.  Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice , 2005, Clinical chemistry and laboratory medicine.

[3]  B. Acunaş,et al.  Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy , 2004, Brain and Development.

[4]  T. Sakabe,et al.  Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery? , 2003, Journal of cardiothoracic and vascular anesthesia.

[5]  L. Rasmussen,et al.  Biochemical markers for brain damage after cardiac surgery – time profile and correlation with cognitive dysfunction , 2002, Acta anaesthesiologica Scandinavica.

[6]  A. Ebert,et al.  Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. , 2000, Stroke.

[7]  D. Harris,et al.  Time course of neurone-specific enolase and S-100 protein release during and after coronary artery bypass grafting. , 1999, British journal of anaesthesia.

[8]  D. Krieger,et al.  Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. , 1997, Critical care medicine.

[9]  W D White,et al.  Defining neuropsychological dysfunction after coronary artery bypass grafting. , 1996, The Annals of thoracic surgery.

[10]  K. Buchanan,et al.  Serum neurone-specific enolase concentrations in patients with neurological disorders. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[11]  T. Treasure,et al.  The Impact of Microemboli During Cardiopulmonary Bypass on Neuropsychological Functioning , 1994, Stroke.

[12]  H. Reiber,et al.  Neuron‐Specific Enolase Concentrations in Blood as a Prognostic Parameter in Cerebrovascular Diseases , 1994, Stroke.

[13]  A. Takahashi,et al.  Prognostic value of cerebrospinal fluid neuron‐specific enolase and S‐100b protein in Guillain‐Barré syndrome , 1994, Acta neurologica Scandinavica.

[14]  G. Borm,et al.  Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. , 1992, Clinical chemistry.

[15]  H. Nozaki,et al.  Neuron-specific enolase in comatose children. , 1988, American journal of diseases of children.

[16]  K. Bergström,et al.  RELEASE OF ADENYLATE KINASE INTO CEREBROSPINAL FLUID DURING OPEN-HEART SURGERY AND ITS RELATION TO POSTOPERATIVE INTELLECTUAL FUNCTION , 1982, The Lancet.